Drug
XL147 clinical trials
Also written SAR245408.
- studies test it
- 12
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Name
Studies by the year they started
12 studies that test it; most in 2011 (4)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 3 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 11
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
Often tested with
Tested in the same studies.
XL765 (3) · Pimasertib hydrochloride (1) · Pimasertib (1) · Seribantumab (1) · Paclitaxel (1) · Carboplatin (1) · Erlotinib (1) · XL647 (1)
Studies
Open first, then newest update. How each study uses XL147 is read from its arms, and is right about nine times in ten.
Testing it · 12
- Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination RegimenCompletedPhase 1/2SanofiNCT01587040Written as SAR245408
- Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast CancerCompletedPhase 1/2SanofiNCT01082068Written as XL147 (SAR245408)
- Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial CarcinomaCompletedPhase 2SanofiNCT01013324Written as XL147 (SAR245408)
- A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or LymphomaCompletedPhase 1SanofiNCT01943838Written as SAR245408
- Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid TumorsCompletedPhase 1SanofiNCT01357330Written as SAR245408 (XL147)
- Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid TumorsWithdrawnPhase 1ExelixisNCT00704392Written as XL147
- Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid TumorsCompletedPhase 1SanofiNCT01392924Written as SAR245408
- A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor CancersCompletedPhase 1SanofiNCT01436565Written as SAR245408
- Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid TumorsCompletedPhase 1SanofiNCT00756847Written as XL147 (SAR245408),
- Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or LymphomaCompletedPhase 1SanofiNCT00486135Written as XL147 (SAR245408)
- Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical ResectionCompletedPhase 1SanofiNCT01240460Written as XL147 (SAR245408)
- Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid TumorsCompletedPhase 1SanofiNCT00692640Written as XL147 (SAR245408)